Certolizumab pegol has a different profile from other anti-TNFs, including golimumab, in a variety of in vitro assays

被引:0
|
作者
G Fossati
A Nesbitt
机构
[1] New Medicines,
[2] UCB,undefined
关键词
Infliximab; Etanercept; Adalimumab; Annexin Versus; Peripheral Blood Lymphocyte;
D O I
10.1186/1479-5876-8-S1-P37
中图分类号
学科分类号
摘要
引用
收藏
相关论文
empty
未找到相关数据